Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors
@article{Kathmann2006CannabidiolIA, title={Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors}, author={M. Kathmann and K. Flau and A. Redmer and C. Tr{\"a}nkle and E. Schlicker}, journal={Naunyn-Schmiedeberg's Archives of Pharmacology}, year={2006}, volume={372}, pages={354-361} }
The mechanism of action of cannabidiol, one of the major constituents of cannabis, is not well understood but a noncompetitive interaction with mu opioid receptors has been suggested on the basis of saturation binding experiments. The aim of the present study was to examine whether cannabidiol is an allosteric modulator at this receptor, using kinetic binding studies, which are particularly sensitive for the measurement of allosteric interactions at G protein-coupled receptors. In addition, we… CONTINUE READING
Paper Mentions
Blog Post
Observational Clinical Trial
The aim of this study is to evaluate the efficacy of oral administration of nabilone or
THC/CBD administration in combination with spinal cord stimulation (SCS) in FBSS patients… Expand
Conditions | FBSS |
---|---|
Intervention | Drug |
192 Citations
Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity
- Chemistry, Medicine
- Neurochemistry International
- 2014
- 27
The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes
- Chemistry, Medicine
- Naunyn-Schmiedeberg's Archives of Pharmacology
- 2007
- 4
- Highly Influenced
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- Chemistry, Medicine
- Front. Pharmacol.
- 2017
- 59
- PDF
Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors
- Chemistry, Medicine
- Neurochemistry International
- 2012
- 18
Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner
- Chemistry, Medicine
- Neuropharmacology
- 2015
- 19
- Highly Influenced
- PDF
Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors.
- Chemistry, Medicine
- European journal of pharmacology
- 2013
- 42
CB1 receptors modulate the intake of a sweetened-fat diet in response to mu-opioid receptor stimulation of the nucleus accumbens
- Chemistry, Medicine
- Pharmacology Biochemistry and Behavior
- 2010
- 31
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain
- Chemistry, Medicine
- PloS one
- 2012
- 62
- PDF
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
- Chemistry, Medicine
- Journal of enzyme inhibition and medicinal chemistry
- 2017
- 17
- PDF
References
SHOWING 1-10 OF 44 REFERENCES
Modulation of rat brain opioid receptors by cannabinoids.
- Chemistry, Medicine
- The Journal of pharmacology and experimental therapeutics
- 1987
- 77
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.
- Chemistry, Medicine
- Life sciences
- 2005
- 413
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
- Biology, Medicine
- Pharmacological Reviews
- 2002
- 2,273
- PDF
Modulation of transmitter release via presynaptic cannabinoid receptors.
- Chemistry, Medicine
- Trends in pharmacological sciences
- 2001
- 606
[3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors.
- Medicine
- Brain research
- 1993
- 1
Modulation of brain α2-adrenoceptor and μ-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats
- Chemistry
- Naunyn-Schmiedeberg's Archives of Pharmacology
- 2004
- 19
(-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens.
- Chemistry, Medicine
- European journal of pharmacology
- 2002
- 117
Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.
- Chemistry, Medicine
- Molecular pharmacology
- 1989
- 70